Dodge & Cox – ALNY history
- Issuer:
- Alnylam Pharmaceuticals, Inc.
- Quarters tracked:
- 40 (Q2 2016 → Q1 2026)
- Current shares:
- 1,929,253
- Current value:
- $638.33M
- Peak shares:
- 9,399,245 (Q1 2017)
- Overall change:
- -23%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 1,929,253 | $638.33M | $330.87 | -35,162 | -2% |
| Q4 2025 | 1,964,415 | $781.15M | $397.65 | -356,815 | -15% |
| Q3 2025 | 2,321,230 | $1.06B | $456.00 | -875,866 | -27% |
| Q2 2025 | 3,197,096 | $1.04B | $326.09 | -154,666 | -5% |
| Q1 2025 | 3,351,762 | $905.04M | $270.02 | -188,500 | -5% |
| Q4 2024 | 3,540,262 | $833.06M | $235.31 | -82,273 | -2% |
| Q3 2024 | 3,622,535 | $996.31M | $275.03 | -157,650 | -4% |
| Q2 2024 | 3,780,185 | $918.59M | $243.00 | -31,295 | -1% |
| Q1 2024 | 3,811,480 | $569.63M | $149.45 | +137,170 | +4% |
| Q4 2023 | 3,674,310 | $703.30M | $191.41 | -72,845 | -2% |
| Q3 2023 | 3,747,155 | $663.62M | $177.10 | -42,370 | -1% |
| Q2 2023 | 3,789,525 | $719.78M | $189.94 | -105,010 | -3% |
| Q1 2023 | 3,894,535 | $780.15M | $200.32 | -696,247 | -15% |
| Q4 2022 | 4,590,782 | $1.09B | $237.65 | -298,515 | -6% |
| Q3 2022 | 4,889,297 | $978.64M | $200.16 | -369,659 | -7% |
| Q2 2022 | 5,258,956 | $767.02M | $145.85 | -216,712 | -4% |
| Q1 2022 | 5,475,668 | $894.12M | $163.29 | +44,600 | +1% |
| Q4 2021 | 5,431,068 | $921.00M | $169.58 | +58,968 | +1% |
| Q3 2021 | 5,372,100 | $1.01B | $188.81 | -41,901 | -1% |
| Q2 2021 | 5,414,001 | $917.78M | $169.52 | +1,092,374 | +25% |
| Q1 2021 | 4,321,627 | $610.17M | $141.19 | -318,286 | -7% |
| Q4 2020 | 4,639,913 | $603.05M | $129.97 | -37,700 | -1% |
| Q3 2020 | 4,677,613 | $681.06M | $145.60 | -26,058 | -1% |
| Q2 2020 | 4,703,671 | $696.66M | $148.11 | -389,675 | -8% |
| Q1 2020 | 5,093,346 | $554.41M | $108.85 | -157,975 | -3% |
| Q4 2019 | 5,251,321 | $604.79M | $115.17 | -60,480 | -1% |
| Q3 2019 | 5,311,801 | $427.18M | $80.42 | +70,300 | +1% |
| Q2 2019 | 5,241,501 | $380.32M | $72.56 | +243,500 | +5% |
| Q1 2019 | 4,998,001 | $467.06M | $93.45 | +307,750 | +7% |
| Q4 2018 | 4,690,251 | $341.97M | $72.91 | +34,600 | +1% |
| Q3 2018 | 4,655,651 | $407.46M | $87.52 | +950 | 0% |
| Q2 2018 | 4,654,701 | $458.44M | $98.49 | -38,140 | -1% |
| Q1 2018 | 4,692,841 | $558.92M | $119.10 | -3,538,754 | -43% |
| Q4 2017 | 8,231,595 | $1.05B | $127.05 | -909,900 | -10% |
| Q3 2017 | 9,141,495 | $1.07B | $117.49 | -44,325 | 0% |
| Q2 2017 | 9,185,820 | $732.66M | $79.76 | -213,425 | -2% |
| Q1 2017 | 9,399,245 | $481.71M | $51.25 | +194,295 | +2% |
| Q4 2016 | 9,204,950 | $344.63M | $37.44 | +3,928,882 | +74% |
| Q3 2016 | 5,276,068 | $357.61M | $67.78 | +2,759,399 | +110% |
| Q2 2016 | 2,516,669 | $139.65M | $55.49 | — | NEW |